LLY
LLY
NYSE · Pharmaceuticals

Eli Lilly and Co.

S&P 500 Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks
$1,058.56
+49.04 (+4.86%)
As of Feb 24, 1:03 PM ET ·
Analyst Consensus
Buy
37
Analysts
Very High
Coverage
Buy 27 73%
Hold 10 27%
Sell 0 0%
Price Target
Analyst Price Target +25.7% upside
Low Target $960.24
Average Target $1,330.33
High Target $1,470.76
Current Price $1,058.56
Current
$1,058.56
Target
$1,330.33
$960.24 $1,330.33 avg $1,470.76
Scenario Analysis
Bear Case
$960.24
-9.3%
Low target
Base Case
$1,330.33
+25.7%
Avg target
Bull Case
$1,470.76
+38.9%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$1,133.95
-6.6% from high
52-Week Low
$623.78
+69.7% from low
50-Day SMA
$1,050.28
+0.8% vs SMA
200-Day SMA
$866.44
+22.2% vs SMA
RSI (14)
49.9
Neutral
Target vs 52W High
$1,330.33
+17.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Buy 37 73% $1,330.33 +25.7%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +21.8%
MRK
Merck & Co. Inc.
 Buy 34 62% $159.27 +28.6%
PFE
Pfizer Inc.
 Hold 33 45% $33.90 +25.3%
BMY
Bristol-Myers Squibb Co
 Hold 34 41% $174.50 +184.9%
ZTS
Zoetis Inc
 Buy 24 67% $209.87 +65.4%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 14 93% $36.26 -18.8%
VTRS
Viatris Inc
 Buy 18 61% $122.82 +670.0%